BNTX logo

BioNTech SE (BNTX) Cash from financing

annual CFF:

-$49.68M+$793.24M(+94.11%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BNTX annual cash flow from financing activities is -$49.68 million, with the most recent change of +$793.24 million (+94.11%) on December 31, 2024.
  • During the last 3 years, BNTX annual CFF has fallen by -$161.14 million (-144.57%).
  • BNTX annual CFF is now -104.86% below its all-time high of $1.02 billion, reached on December 31, 2020.

Performance

BNTX Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

quarterly CFF:

-$14.52M-$7.29M(-100.92%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX quarterly cash flow from financing activities is -$14.52 million, with the most recent change of -$7.29 million (-100.92%) on March 1, 2025.
  • Over the past year, BNTX quarterly CFF has dropped by -$6.05 million (-71.39%).
  • BNTX quarterly CFF is now -101.94% below its all-time high of $747.05 million, reached on September 30, 2020.

Performance

BNTX quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

TTM CFF:

-$55.73M-$6.05M(-12.17%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX TTM cash flow from financing activities is -$55.73 million, with the most recent change of -$6.05 million (-12.17%) on March 1, 2025.
  • Over the past year, BNTX TTM CFF has increased by +$482.80 million (+89.65%).
  • BNTX TTM CFF is now -105.27% below its all-time high of $1.06 billion, reached on September 30, 2020.

Performance

BNTX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BNTX Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+94.1%-71.4%+89.7%
3 y3 years-144.6%-116.1%-126.9%
5 y5 years-111.6%-757.9%-113.0%

BNTX Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-144.6%+96.7%-116.1%+98.3%-126.9%+97.1%
5 y5-year-104.9%+96.7%-101.9%+98.3%-105.3%+97.1%
alltimeall time-104.9%+96.7%-101.9%+98.3%-105.3%+97.1%

BNTX Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$14.52M(+100.9%)
-$55.73M(+12.2%)
Dec 2024
-$49.68M(-94.1%)
-$7.23M(-23.1%)
-$49.68M(-3.9%)
Sep 2024
-
-$9.40M(-61.8%)
-$51.69M(-86.4%)
Jun 2024
-
-$24.58M(+190.2%)
-$380.15M(-29.4%)
Mar 2024
-
-$8.47M(-8.3%)
-$538.52M(-36.1%)
Dec 2023
-$842.92M(-43.7%)
-$9.24M(-97.3%)
-$842.92M(-12.7%)
Sep 2023
-
-$337.86M(+84.7%)
-$965.88M(-22.5%)
Jun 2023
-
-$182.95M(-41.5%)
-$1.25B(-34.4%)
Mar 2023
-
-$312.87M(+136.7%)
-$1.90B(+26.9%)
Dec 2022
-$1.50B(-1442.9%)
-$132.20M(-78.6%)
-$1.50B(+5.3%)
Sep 2022
-
-$617.69M(-26.2%)
-$1.42B(+74.6%)
Jun 2022
-
-$837.00M(-1028.9%)
-$814.29M(-493.4%)
Mar 2022
-
$90.11M(-257.3%)
$206.98M(+85.7%)
DateAnnualQuarterlyTTM
Dec 2021
$111.46M(-89.1%)
-$57.27M(+465.6%)
$111.46M(-60.2%)
Sep 2021
-
-$10.13M(-105.5%)
$280.23M(-73.0%)
Jun 2021
-
$184.27M(-3498.2%)
$1.04B(+2.3%)
Mar 2021
-
-$5.42M(-104.9%)
$1.01B(-0.7%)
Dec 2020
$1.02B(+138.1%)
$111.51M(-85.1%)
$1.02B(-3.4%)
Sep 2020
-
$747.05M(+364.0%)
$1.06B(+80.2%)
Jun 2020
-
$161.01M(+7195.0%)
$586.79M(+36.4%)
Mar 2020
-
$2.21M(-98.5%)
$430.22M(+0.3%)
Dec 2019
$429.10M(-0.5%)
$146.98M(-46.9%)
$429.10M(+52.1%)
Sep 2019
-
$276.59M(+6134.4%)
$282.12M(+5005.3%)
Jun 2019
-
$4.44M(+307.3%)
$5.53M(+407.3%)
Mar 2019
-
$1.09M
$1.09M
Dec 2018
$431.20M(<-9900.0%)
-
-
Dec 2017
-$1.86M
-
-

FAQ

  • What is BioNTech SE annual cash flow from financing activities?
  • What is the all time high annual CFF for BioNTech SE?
  • What is BioNTech SE annual CFF year-on-year change?
  • What is BioNTech SE quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for BioNTech SE?
  • What is BioNTech SE quarterly CFF year-on-year change?
  • What is BioNTech SE TTM cash flow from financing activities?
  • What is the all time high TTM CFF for BioNTech SE?
  • What is BioNTech SE TTM CFF year-on-year change?

What is BioNTech SE annual cash flow from financing activities?

The current annual CFF of BNTX is -$49.68M

What is the all time high annual CFF for BioNTech SE?

BioNTech SE all-time high annual cash flow from financing activities is $1.02B

What is BioNTech SE annual CFF year-on-year change?

Over the past year, BNTX annual cash flow from financing activities has changed by +$793.24M (+94.11%)

What is BioNTech SE quarterly cash flow from financing activities?

The current quarterly CFF of BNTX is -$14.52M

What is the all time high quarterly CFF for BioNTech SE?

BioNTech SE all-time high quarterly cash flow from financing activities is $747.05M

What is BioNTech SE quarterly CFF year-on-year change?

Over the past year, BNTX quarterly cash flow from financing activities has changed by -$6.05M (-71.39%)

What is BioNTech SE TTM cash flow from financing activities?

The current TTM CFF of BNTX is -$55.73M

What is the all time high TTM CFF for BioNTech SE?

BioNTech SE all-time high TTM cash flow from financing activities is $1.06B

What is BioNTech SE TTM CFF year-on-year change?

Over the past year, BNTX TTM cash flow from financing activities has changed by +$482.80M (+89.65%)
On this page